Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the effect of baricitinib 4-mg once daily (QD) or 2-mg daily QD compared to placebo on remission of SLE arthritis and/or rash in patients with SLE receiving concomitant standard therapy over 24 weeks.
Critère d'inclusion
- Patients with Systemic Lupus Erythematosus (SLE)